Loading viewer...
investor_presentation
Format: PDF investor_presentation
Antibe Therapeutics investor presentation from September 2019 focusing on the company's innovation in pain and inflammation treatment. The presentation outlines the company's research and development activities, future operating strategies, and clinical product candidates addressing pervasive medical challenges.
investor_presentation
DocuSign
Greenbrier Companies GBX June 2023 Investor Presentation
investor_presentationinvestor_presentation
46 Pages
The Greenbrier Companies, Inc.